Nilda Süslü
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Nilda Süslü has a total of 72 co-authors. Here are the top co-authors by number of shared publications:
- Taner Yılmaz
Department of Otolaryngology-Head & Neck Surgery, Hacettepe University Faculty of Medicine, Ankara, Turkey
7 shared publications - Oğuz Kuşcu
Department of Otorhinolaryngology, Faculty of Medicine, Hacettepe University, Ankara, Türkiye
5 shared publications Umut Akyol
Department of Otorhinolaryngology, Hacettepe University Faculty of Medicine, Ankara, Turkey
3 shared publications- Yeşim Gaye Güler Tezel
Department of Pathology, Hacettepe University Medical School
3 shared publications A. Şefik Hoşal
Department of Otorhinolaryngology - Head and Neck Surgery, Hacettepe University Faculty of Medicine, Turkey
2 shared publications- Ahmet Erim Pamuk
Department of Otorhinolaryngology, Hacettepe University, Ankara, Turkey
2 shared publications
Latest Publications
- 28 October 2025
- Published by Taylor & Francis in Acta Oto-Laryngologica
- Vol. 145 (12) , 1199-1207
Comparative evaluation of ChatGPT-4o and DeepSeek-V3 in head and neck oncology
Large language models (LLMs) are increasingly used in clinical decision-making and patient education, including in complex specialties such as head and neck cancer (HNC). To evaluate the performance of ChatGPT-4o and DeepSeek-V3 in answering HNC-related clinical questions. A set of 154 questions across six clinical categories was submitted twice to both models. Responses were independently graded by head and neck surgeons using a four-point accuracy scale. Accuracy, reproducibility, and inter-model agreement were assessed. ChatGPT-4o and DeepSeek-V3 provided ''comprehensive/correct'' answers in 92.2% and 89.6% of cases, respectively (p = .42). The accuracy ratings of both models' responses overlapped in 85.1% of cases; however, the statistical agreement between them remained low (Cohen's κ = 0.12; ICC = 0.21, p = .006). DeepSeek-V3 outperformed ChatGPT in Treatment category (96.3% vs. 81.5%, p = .08), while ChatGPT excelled in Recovery, Complications, and Follow-up (95.0% vs. 82.5%, p = .08); however, these differences did not reach statistical significance. Reproducibility was high for both models (ChatGPT-4o: 96.1%; DeepSeek-V3: 96.8%). Both models demonstrated strong accuracy and consistency in HNC-related queries. LLMs hold promise as reliable tools in clinical decision-making and patient education within HNCs when used with careful consideration of their inherent limitations.
- 28 October 2025
- Published by Taylor & Francis in Acta Oto-Laryngologica
- Vol. 145 (12) , 1199-1207
Comparative evaluation of ChatGPT-4o and DeepSeek-V3 in head and neck oncology
Large language models (LLMs) are increasingly used in clinical decision-making and patient education, including in complex specialties such as head and neck cancer (HNC). To evaluate the performance of ChatGPT-4o and DeepSeek-V3 in answering HNC-related clinical questions. A set of 154 questions across six clinical categories was submitted twice to both models. Responses were independently graded by head and neck surgeons using a four-point accuracy scale. Accuracy, reproducibility, and inter-model agreement were assessed. ChatGPT-4o and DeepSeek-V3 provided ''comprehensive/correct'' answers in 92.2% and 89.6% of cases, respectively (p = .42). The accuracy ratings of both models' responses overlapped in 85.1% of cases; however, the statistical agreement between them remained low (Cohen's κ = 0.12; ICC = 0.21, p = .006). DeepSeek-V3 outperformed ChatGPT in Treatment category (96.3% vs. 81.5%, p = .08), while ChatGPT excelled in Recovery, Complications, and Follow-up (95.0% vs. 82.5%, p = .08); however, these differences did not reach statistical significance. Reproducibility was high for both models (ChatGPT-4o: 96.1%; DeepSeek-V3: 96.8%). Both models demonstrated strong accuracy and consistency in HNC-related queries. LLMs hold promise as reliable tools in clinical decision-making and patient education within HNCs when used with careful consideration of their inherent limitations.
- 17 October 2025
- Published by Taylor & Francis in Logopedics Phoniatrics Vocology
- Vol. 51 (1) , 19-28
Comparison of olfactory functions of individuals with total laryngectomy using different voice restoration methods
To investigate whether there is a difference in olfactory functions among individuals who use different voice restoration methods after total laryngectomy. The study group for this research comprised individuals who had undergone total laryngectomy and aged 44 to 75 years; 10 participants using oesophageal speech, 10 participants using tracheoesophageal speech, and 10 participants using electrolarynx were included. The control group comprised 10 individuals with normal olfactory function of similar age and gender to the individuals in the study group. The participants' olfactory functions were evaluated using the Sniffin Sticks Extended Test. European Organisation for Research and Treatment of Cancer Quality of Life Questionnaire - H&N-35 was used as a subjective scale. All laryngectomised patients exhibited olfactory impairment, with 73.3% diagnosed with anosmia and 26.7% with hyposmia. Regarding Sniffin Sticks Test combined scores; the mean values of voice prosthesis users, electrolarynx and oesophageal speech group were 8.4, 10.1 and 21.6 respectively, while in the control group it was 38.2. In terms of Sniffin Sticks Test composite scores, the oesophageal speech group had significantly higher scores than the voice prosthesis and electrolarynx groups (p < 0.001). While all laryngectomised patients showed olfactory dysfunction, those using oesophageal speech - a somewhat overlooked rehabilitation method - exhibited statistically significant preservation of olfactory function compared to other voice restoration techniques. These findings suggest that oesophageal speech may offer distinct advantages for maintaining post-laryngectomy olfactory capacity, warranting further consideration in clinical practise.
- 17 October 2025
- Published by Taylor & Francis in Logopedics Phoniatrics Vocology
- Vol. 51 (1) , 19-28
Comparison of olfactory functions of individuals with total laryngectomy using different voice restoration methods
To investigate whether there is a difference in olfactory functions among individuals who use different voice restoration methods after total laryngectomy. The study group for this research comprised individuals who had undergone total laryngectomy and aged 44 to 75 years; 10 participants using oesophageal speech, 10 participants using tracheoesophageal speech, and 10 participants using electrolarynx were included. The control group comprised 10 individuals with normal olfactory function of similar age and gender to the individuals in the study group. The participants' olfactory functions were evaluated using the Sniffin Sticks Extended Test. European Organisation for Research and Treatment of Cancer Quality of Life Questionnaire - H&N-35 was used as a subjective scale. All laryngectomised patients exhibited olfactory impairment, with 73.3% diagnosed with anosmia and 26.7% with hyposmia. Regarding Sniffin Sticks Test combined scores; the mean values of voice prosthesis users, electrolarynx and oesophageal speech group were 8.4, 10.1 and 21.6 respectively, while in the control group it was 38.2. In terms of Sniffin Sticks Test composite scores, the oesophageal speech group had significantly higher scores than the voice prosthesis and electrolarynx groups (p < 0.001). While all laryngectomised patients showed olfactory dysfunction, those using oesophageal speech - a somewhat overlooked rehabilitation method - exhibited statistically significant preservation of olfactory function compared to other voice restoration techniques. These findings suggest that oesophageal speech may offer distinct advantages for maintaining post-laryngectomy olfactory capacity, warranting further consideration in clinical practise.
- 12 September 2025
- Published by Taylor & Francis in Acta Oto-Laryngologica
- p. 1-9
Validation of sentinel lymph node biopsy with completion neck dissection in oral cavity cancer
Sentinel lymph node biopsy (SLNB) is increasingly used in oral cavity squamous cell carcinoma (OCSCC) as a minimally invasive approach that may reduce overtreatment and morbidity compared to elective neck dissection (END). This study evaluated the diagnostic performance of SLNB in clinically node-negative (cN0) OCSCC and its utility in mapping lymphatic drainage, particularly in advanced tumors. A retrospective cohort of 57 cN0 OCSCC patients undergoing SLNB followed by completion neck dissection was analysed. In early-stage tumors (T1/T2), SLNB demonstrated 100% sensitivity and negative predictive value, with an occult metastasis rate of 23.8%. No false negatives were observed, and only one patient was upstaged. In T3/T4 tumors, sensitivity and NPV decreased to 55.6% and 60%. The false-negative rate (FNR), calculated as the proportion of false negatives among patients with histopathologically confirmed nodal metastases, was 44.4%. Contralateral or bilateral drainage occurred in 40% of well-lateralized advanced tumors, reflecting altered drainage with progression. SLNB is a reliable staging tool in early OCSCC. In advanced disease, although diagnostic accuracy is reduced, it provides valuable information on atypical drainage pathways. These findings support SLNB as an effective staging and lymphatic mapping tool, reinforcing its selective integration into OCSCC management.
- 12 September 2025
- Published by Taylor & Francis in Acta Oto-Laryngologica
- p. 1-9
Validation of sentinel lymph node biopsy with completion neck dissection in oral cavity cancer
Sentinel lymph node biopsy (SLNB) is increasingly used in oral cavity squamous cell carcinoma (OCSCC) as a minimally invasive approach that may reduce overtreatment and morbidity compared to elective neck dissection (END). This study evaluated the diagnostic performance of SLNB in clinically node-negative (cN0) OCSCC and its utility in mapping lymphatic drainage, particularly in advanced tumors. A retrospective cohort of 57 cN0 OCSCC patients undergoing SLNB followed by completion neck dissection was analysed. In early-stage tumors (T1/T2), SLNB demonstrated 100% sensitivity and negative predictive value, with an occult metastasis rate of 23.8%. No false negatives were observed, and only one patient was upstaged. In T3/T4 tumors, sensitivity and NPV decreased to 55.6% and 60%. The false-negative rate (FNR), calculated as the proportion of false negatives among patients with histopathologically confirmed nodal metastases, was 44.4%. Contralateral or bilateral drainage occurred in 40% of well-lateralized advanced tumors, reflecting altered drainage with progression. SLNB is a reliable staging tool in early OCSCC. In advanced disease, although diagnostic accuracy is reduced, it provides valuable information on atypical drainage pathways. These findings support SLNB as an effective staging and lymphatic mapping tool, reinforcing its selective integration into OCSCC management.
- Open Access
- 7 October 2024
- Published by Wiley in The Laryngoscope
- Vol. 135 (2) , 809-817
Swallowing Kinematics in Male Patients with Total Laryngectomy
Objective: The present study aimed to investigate the symptomatic swallowing complaints in individuals with total laryngectomy (TL) and reveal how swallowing kinematics differs between those with and without symptomatic dysphagia complaints.Methods: A total of 34 subjects with TL were included in the study. Swallowing kinematics of those with symptomatic swallowing complaints (Group 1) were compared to those without (Group 2). Kinematic parameters including pharyngeal transit duration (PTD), maximum pharyngeal constriction ratio (MPCR), upper esophageal sphincter opening ratio (UESOR), upper esophageal sphincter opening duration (UESOD), and bolus clearance ratio (BCR) were investigated from Videofluoroscopic Swallowing Study (VFSS) records via ImageJ software.Results: Symptomatic swallowing complaints were determined in 47.1% of the subjects (n = 16). Difficulty while swallowing solid foods and pills, diminished pleasure of eating, food getting stuck in the throat, and increased level of stress during swallowing were among the major swallowing complaints in the present cohort. PTD, MPCR, and BCR parameters were significantly higher in subjects with symptomatic swallowing complaints than those without.Conclusion: These preliminary findings indicate that almost half of individuals with TL may have symptomatic swallowing complaints. The underlying pathophysiology of this phenomenon may be the devianced kinematic parameters including PTD, MPCR, and BCR in this population. Therefore, it is recommended to include the kinematic measurements in the dysphagia evaluation protocol in individuals with TL, most notably in those with symptomatic swallowing complaints.Level of Evidence: 3 Laryngoscope, 135:809–817, 2025
- 7 October 2024
- Published by Wiley in The Laryngoscope
- Vol. 135 (2) , 809-817
Open AccessSwallowing Kinematics in Male Patients with Total Laryngectomy
Objective: The present study aimed to investigate the symptomatic swallowing complaints in individuals with total laryngectomy (TL) and reveal how swallowing kinematics differs between those with and without symptomatic dysphagia complaints.Methods: A total of 34 subjects with TL were included in the study. Swallowing kinematics of those with symptomatic swallowing complaints (Group 1) were compared to those without (Group 2). Kinematic parameters including pharyngeal transit duration (PTD), maximum pharyngeal constriction ratio (MPCR), upper esophageal sphincter opening ratio (UESOR), upper esophageal sphincter opening duration (UESOD), and bolus clearance ratio (BCR) were investigated from Videofluoroscopic Swallowing Study (VFSS) records via ImageJ software.Results: Symptomatic swallowing complaints were determined in 47.1% of the subjects (n = 16). Difficulty while swallowing solid foods and pills, diminished pleasure of eating, food getting stuck in the throat, and increased level of stress during swallowing were among the major swallowing complaints in the present cohort. PTD, MPCR, and BCR parameters were significantly higher in subjects with symptomatic swallowing complaints than those without.Conclusion: These preliminary findings indicate that almost half of individuals with TL may have symptomatic swallowing complaints. The underlying pathophysiology of this phenomenon may be the devianced kinematic parameters including PTD, MPCR, and BCR in this population. Therefore, it is recommended to include the kinematic measurements in the dysphagia evaluation protocol in individuals with TL, most notably in those with symptomatic swallowing complaints.Level of Evidence: 3 Laryngoscope, 135:809–817, 2025
- 1 January 2023
- Published by Taylor & Francis in Biomarkers in Medicine
- Vol. 17 (2) , 87-99
Evaluation of Sarcopenia As A Prognostic Biomarker in Locally Advanced Head and Neck Squamous Cell Carcinoma
Background: We aimed to evaluate the effect of sarcopenia on survival in head and neck squamous cell carcinoma patients treated with chemoradiotherapy. Materials & methods: Disease-free survival an... Plain language summary Head and neck cancer is one of the main causes of cancer-related death worldwide. Most patients are diagnosed in the advanced stage. Muscle wasting with significant weight lo... Tweetable abstract Sarcopenia may be a potential prognostic biomarker for head and neck squamous cell carcinoma patients. Sarcopenic patients have significantly worse survival rates and are more su...
- 1 January 2023
- Published by Taylor & Francis in Biomarkers in Medicine
- Vol. 17 (2) , 87-99
Evaluation of Sarcopenia As A Prognostic Biomarker in Locally Advanced Head and Neck Squamous Cell Carcinoma
Background: We aimed to evaluate the effect of sarcopenia on survival in head and neck squamous cell carcinoma patients treated with chemoradiotherapy. Materials & methods: Disease-free survival an... Plain language summary Head and neck cancer is one of the main causes of cancer-related death worldwide. Most patients are diagnosed in the advanced stage. Muscle wasting with significant weight lo... Tweetable abstract Sarcopenia may be a potential prognostic biomarker for head and neck squamous cell carcinoma patients. Sarcopenic patients have significantly worse survival rates and are more su...
- 1 November 2022
- Published by Elsevier in Brazilian Journal of Otorhinolaryngology (Versão em Português)
- Vol. 88 (6) , 968-974
Proteína tipo‐lisil oxidase‐4 (LOXL4) como marcador tumoral e prognóstico no câncer de laringe em estágio avançado
- 1 November 2022
- Published by Elsevier in Brazilian Journal of Otorhinolaryngology (Versão em Português)
- Vol. 88 (6) , 968-974
Proteína tipo‐lisil oxidase‐4 (LOXL4) como marcador tumoral e prognóstico no câncer de laringe em estágio avançado
- Open Access
- 1 November 2022
- Published by Elsevier in Brazilian Journal of Otorhinolaryngology
- Vol. 88 (6) , 968-974
Lysyl Oxidase Like-4 (LOXL4) as a tumor marker and prognosticator in advanced stage laryngeal cancer
- 1 November 2022
- Published by Elsevier in Brazilian Journal of Otorhinolaryngology
- Vol. 88 (6) , 968-974
Open AccessLysyl Oxidase Like-4 (LOXL4) as a tumor marker and prognosticator in advanced stage laryngeal cancer
- 19 June 2021
- Published by Springer Nature in European Archives of Oto-Rhino-Laryngology
- Vol. 279 (3) , 1549-1560
Role of indocyanine green combined with radiotracer-Technetium 99 m in neck surgery for primary and recurrent head and neck cancer: preliminary results of a tertiary cancer center
Purpose Neck dissection (ND), whether therapeutic or elective, is an essential component of the treatment of head and neck squamous cell carcinoma (HNSCC). Due to altered anatomy and fibrosis caused by initial treatments, surgeons face challenges during salvage ND. A combination of Technetium-99 m and indocyanine green (ICG) previously used in the sentinel lymph node (SLN) biopsy for oral cavity cancers, may be useful in different types of neck surgeries. We aimed to show the additional advantage of this combination in detecting HNSCC and thyroid cancer recurrences, as well as individual lymphatic drainage in elective ND. Methods We retrospectively reviewed medical records of patients, underwent neck surgery guided with ICG and Tc-99 m, in Hacettepe University Hospital between June 2018 and December 2020. In a total of 28 patients, intraoperative gamma probes were paired with near infrared (NIR) cameras. Patients are divided into two groups: neck surgery with recurrent occult lesion localization (NS- ROLL) (n: 14) and ND with SLN screening (ND-SLNS) (n: 14). Results Among all 14 patients in NS-ROLL group, recurrent diseases, hidden behind tissues were 100% successfully localized. In ND-SLNS group, 238 lymph nodes were harvested, metastasis rate was 31.3% (10/32) in sentinel nodes. SLNS revealed 100% accuracy in detecting metastasis in clinically N0 neck (10/238). Contralateral lymphatic drainage was observed in three patients (lateral-sided oral cavity SCC). In two patients (floor of mouth), three sentinel nodes were detected by NIR only. Conclusion The use of ICG-radiotracer provides additional value in disease removal for both primary and recurrent tumors of the head and neck.
- 19 June 2021
- Published by Springer Nature in European Archives of Oto-Rhino-Laryngology
- Vol. 279 (3) , 1549-1560
Role of indocyanine green combined with radiotracer-Technetium 99 m in neck surgery for primary and recurrent head and neck cancer: preliminary results of a tertiary cancer center
Purpose Neck dissection (ND), whether therapeutic or elective, is an essential component of the treatment of head and neck squamous cell carcinoma (HNSCC). Due to altered anatomy and fibrosis caused by initial treatments, surgeons face challenges during salvage ND. A combination of Technetium-99 m and indocyanine green (ICG) previously used in the sentinel lymph node (SLN) biopsy for oral cavity cancers, may be useful in different types of neck surgeries. We aimed to show the additional advantage of this combination in detecting HNSCC and thyroid cancer recurrences, as well as individual lymphatic drainage in elective ND. Methods We retrospectively reviewed medical records of patients, underwent neck surgery guided with ICG and Tc-99 m, in Hacettepe University Hospital between June 2018 and December 2020. In a total of 28 patients, intraoperative gamma probes were paired with near infrared (NIR) cameras. Patients are divided into two groups: neck surgery with recurrent occult lesion localization (NS- ROLL) (n: 14) and ND with SLN screening (ND-SLNS) (n: 14). Results Among all 14 patients in NS-ROLL group, recurrent diseases, hidden behind tissues were 100% successfully localized. In ND-SLNS group, 238 lymph nodes were harvested, metastasis rate was 31.3% (10/32) in sentinel nodes. SLNS revealed 100% accuracy in detecting metastasis in clinically N0 neck (10/238). Contralateral lymphatic drainage was observed in three patients (lateral-sided oral cavity SCC). In two patients (floor of mouth), three sentinel nodes were detected by NIR only. Conclusion The use of ICG-radiotracer provides additional value in disease removal for both primary and recurrent tumors of the head and neck.
- 2 April 2021
- Published by Springer Nature in Cell and Tissue Banking
- Vol. 23 (1) , 93-100
Human laryngeal squamous cell carcinoma cell line release of endogenous anandamide and 2-arachidonoylglycerol, and their antiproliferative effect via exogenous supplementation: an in vitro study
The level of the major endocannabinoids anandamide (AEA) and 2-arachidonoylglycerol (2-AG) are altered in several types of carcinomas, and are known to regulate tumor growth. Thusly, this study hypothesized that the HEp-2 human laryngeal squamous cell carcinoma (LSCC) cell line releases AEA and 2-AG, and aimed to determine if their exogenous supplementation has an anti-proliferative effect in vitro. In this in vitro observational study a commercial human LSCC cell line (HEp-2) was used to test for endogenous AEA and 2-AG release via liquid chromatography-tandem mass spectrometry (LC–MS/MS). The anti-proliferative effect of AEA and 2-AG supplementation was evaluated via WST-1 proliferation assay. It was observed that the HEp-2 LSCC cell line released AEA and 2-AG; the median quantity of AEA released was 15.69 ng mL–1 (range: 14.55–15.95 ng mL–1) and the median quantity of 2-AG released was 2.72 ng –1 (range: 2.67–2.74 ng mL–1). Additionally, both AEA and 2-AG exhibited an anti-proliferative effect. The anti-proliferative effect of 2-AG was stronger than that of AEA. These findings suggest that AEA might function via a CB1 receptor-independent pathway and that 2-AG might function via a CB2-dependent pathway. The present findings show that the HEp-2 LSCC cell line releases the major endocannabinoids AEA and 2-AG, and that their supplementation inhibits tumor cell proliferation in vitro. Thus, cannabinoid ligands might represent novel drug candidates for laryngeal cancers, although functional in vivo studies are required in order to validate their potency.
- 2 April 2021
- Published by Springer Nature in Cell and Tissue Banking
- Vol. 23 (1) , 93-100
Human laryngeal squamous cell carcinoma cell line release of endogenous anandamide and 2-arachidonoylglycerol, and their antiproliferative effect via exogenous supplementation: an in vitro study
The level of the major endocannabinoids anandamide (AEA) and 2-arachidonoylglycerol (2-AG) are altered in several types of carcinomas, and are known to regulate tumor growth. Thusly, this study hypothesized that the HEp-2 human laryngeal squamous cell carcinoma (LSCC) cell line releases AEA and 2-AG, and aimed to determine if their exogenous supplementation has an anti-proliferative effect in vitro. In this in vitro observational study a commercial human LSCC cell line (HEp-2) was used to test for endogenous AEA and 2-AG release via liquid chromatography-tandem mass spectrometry (LC–MS/MS). The anti-proliferative effect of AEA and 2-AG supplementation was evaluated via WST-1 proliferation assay. It was observed that the HEp-2 LSCC cell line released AEA and 2-AG; the median quantity of AEA released was 15.69 ng mL–1 (range: 14.55–15.95 ng mL–1) and the median quantity of 2-AG released was 2.72 ng –1 (range: 2.67–2.74 ng mL–1). Additionally, both AEA and 2-AG exhibited an anti-proliferative effect. The anti-proliferative effect of 2-AG was stronger than that of AEA. These findings suggest that AEA might function via a CB1 receptor-independent pathway and that 2-AG might function via a CB2-dependent pathway. The present findings show that the HEp-2 LSCC cell line releases the major endocannabinoids AEA and 2-AG, and that their supplementation inhibits tumor cell proliferation in vitro. Thus, cannabinoid ligands might represent novel drug candidates for laryngeal cancers, although functional in vivo studies are required in order to validate their potency.
- 20 January 2021
- Published by Springer Nature in European Archives of Oto-Rhino-Laryngology
- Vol. 278 (10) , 3933-3940
Fat transfer after parotidectomy: fat resorption rates, aesthetic and functional outcomes of en-bloc fat graft versus lipofilling technique
Purpose Reconstruction of parotidectomy involves the correction of facial contour abnormalities and prevention from Frey Syndrome. Reconstruction of parotidectomy field with autologous fat has not been popular among head and neck surgeons due to unclear predictability of fat resorption rates. The aim of this paper is to compare the fat resorption rates between different fat transfer techniques using radiologic measurements and reviewing the aesthetic and functional outcomes. Methods We retrospectively reviewed medical records of patients, who underwent parotidectomy in Hacettepe University Hospital between 2015 and 2018. The aesthetic and functional outcomes of en-bloc fat graft and lipofilling techniques were compared among themselves, as well as with patients who had no reconstruction, using objective parameters. Fat resorption rates were compared using calculation of fat volumes obtained by MRI scans, 1 year after surgery. Results Among 77 patients, 26 underwent reconstruction with en-bloc fat graft (P-EBFG); 21 patients reconstruction with lipofilling technique (P-LFT), whereas 30 patients had no reconstruction of parotidectomy field (P-NR). In three groups, there was no statistically significant difference in mean resected parotid tissue volumes (mean 18 ± 10.8 cm3, p = 0.754). We found a significant difference in decreased presence of Frey Syndrome and increased satisfation rates of cosmetic appearance in P-EBFG and P-LFT, in comparison to P-NR (p < 0.001). There was no significant difference in fat resorption rates between P-EBFG (50.75 + 21.20%) and P-LFT (48.59 + 17.93%) (p = 0.771). Conclusion Both en-bloc fat graft and lipofilling techniques have been found to be safe and to have similar fat resorption rates for reconstruction after parotidectomy.
- 20 January 2021
- Published by Springer Nature in European Archives of Oto-Rhino-Laryngology
- Vol. 278 (10) , 3933-3940
Fat transfer after parotidectomy: fat resorption rates, aesthetic and functional outcomes of en-bloc fat graft versus lipofilling technique
Purpose Reconstruction of parotidectomy involves the correction of facial contour abnormalities and prevention from Frey Syndrome. Reconstruction of parotidectomy field with autologous fat has not been popular among head and neck surgeons due to unclear predictability of fat resorption rates. The aim of this paper is to compare the fat resorption rates between different fat transfer techniques using radiologic measurements and reviewing the aesthetic and functional outcomes. Methods We retrospectively reviewed medical records of patients, who underwent parotidectomy in Hacettepe University Hospital between 2015 and 2018. The aesthetic and functional outcomes of en-bloc fat graft and lipofilling techniques were compared among themselves, as well as with patients who had no reconstruction, using objective parameters. Fat resorption rates were compared using calculation of fat volumes obtained by MRI scans, 1 year after surgery. Results Among 77 patients, 26 underwent reconstruction with en-bloc fat graft (P-EBFG); 21 patients reconstruction with lipofilling technique (P-LFT), whereas 30 patients had no reconstruction of parotidectomy field (P-NR). In three groups, there was no statistically significant difference in mean resected parotid tissue volumes (mean 18 ± 10.8 cm3, p = 0.754). We found a significant difference in decreased presence of Frey Syndrome and increased satisfation rates of cosmetic appearance in P-EBFG and P-LFT, in comparison to P-NR (p < 0.001). There was no significant difference in fat resorption rates between P-EBFG (50.75 + 21.20%) and P-LFT (48.59 + 17.93%) (p = 0.771). Conclusion Both en-bloc fat graft and lipofilling techniques have been found to be safe and to have similar fat resorption rates for reconstruction after parotidectomy.